MedTrace Logo

Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction

NCT03882775 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2019-03-20

No results posted yet for this study

Summary

The study is an investigator-sponsored, prospective, multicenter, randomized, open-label study designed to compare efficacy and safety between bivalirudin and heparin in elderly patients with acute ST-segment elevation myocardial infarction undergoing emergency PCI.

Conditions

  • STEMI
  • Percutaneous Coronary Intervention
  • Aged

Interventions

DRUG

Bivalirudin

Patients would be given anticoagulant therapy with bivalirudin in acute STEMI during emergency PCI operation.

DRUG

Heparin

heparin with or without gpi during emergency PCI.

Sponsors & Collaborators

  • Beijing Friendship Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Dalian Medical University

    lead OTHER

Principal Investigators

  • Rongchong Huang, M.D. · The First Affiliated Hospital of Dalian Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-16
Primary Completion
2020-07-14
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03882775 on ClinicalTrials.gov